WHO Reports Major Gaps in Global Fight Against AMR

The World Health Organisation (WHO) has issued a warning regarding the global fight against drug-resistant infections, highlighting issues such as inadequate funding, poor diagnostic facilities, and weak implementation of national policies. Despite 173 countries developing national action plans to combat antimicrobial resistance (AMR), only 22 percent have adequately funded and fully implemented their strategies.
This marks an improvement from 79 countries in 2017, but the gap between policy commitments and actual implementation remains a significant challenge. WHO estimates that one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics in 2023.
WHO Director-General Dr Tedros Adhanom Ghebreyesus emphasized the need for governments to translate commitments into action, advocating for increased investment in infection prevention and quality diagnostic services. The 2026 Tracking Antimicrobial Resistance Country Self-Assessment Survey (TrACSS) revealed that only 36 percent of countries have national reference laboratories capable of testing selected pathogens, falling short of the 80 percent target by 2030.
Additionally, only 63 percent of countries have guidelines for appropriate antimicrobial use.
Read the original



